Mirova’s Dentsply Sirona XRAY Stock Holding History

Mirova’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-701	Closed	-$28.1K	–	160
2023 Q2	$28.1K	Sell	701 -1,172	-63%	-$46.6K	﹤0.01%	158
2023 Q1	$73.6K	Buy	+1,873	New	+$68.8K	0.01%	158

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirova's XRAY Position: Q3 2023 in Review

Mirova sold out of Dentsply Sirona (XRAY) in Q3 2023, closing a stake of 701 shares — an estimated $28.1K sold.

Mirova first reported a position in XRAY in Q1 2023 and held it in 2 quarters. The position peaked at $73.6K in Q1 2023. 474 funds tracked by Wall St. Rank hold XRAY as of Q3 2023.

Mirova reported no remaining Dentsply Sirona position as of Q3 2023 after selling out during the quarter.
Mirova sold 701 Dentsply Sirona shares in Q3 2023, an estimated $28.1K.
Mirova first reported a position in Dentsply Sirona in Q1 2023 and held it in 2 quarters.
Mirova's Dentsply Sirona position peaked at $73.6K in Q1 2023.
474 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2023.

Based on Mirova's 13F filing for Q3 2023, filed 14 Nov 2023.